Welcome to a special episode of RealTalk MS coming to you from Day Two of ECTRIMS 2019 in Stockholm, Sweden. ECTRIMS is an acronym that stands for the European Conference for Treatment & Research in Multiple Sclerosis, and this annual scientific congress is the largest MS research conference in the world. There are over 9,000 attendees here from more than 100 different countries to share new information, hear research updates, and get face to face with the leading MS researchers in the world.
We're talking about stem cell therapy, the long-term outcomes of MS, new data about Ocrevus, the importance of managing comorbidities, and a new global initiative that puts the voice of people living with MS at the center of MS research and MS care.
We have a lot to talk about. Welcome to ECTRIMS 2019!
___________
LINKS
If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com
Give RealTalk MS a Rating & Review
ECTRIMS 2019 Scientific Programme
Download the RealTalk MS App for iOS
Download the RealTalk MS App for Android
___________
Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com.
RealTalk MS ECTRIMS Day 2
Hosted By: Jon Strum
Tags: MS, MultipleSclerosis, ECTRIMS2019, EMDSerono, Stemcells, PROMS, RealTalkMS
We're talking about some of the announcements that we expect to hear from some of the pharmaceutical companies in attendance. And we'll also tell you about a session that you'll be able to catch on a live webcast tomorrow morning.